MX9703461A - Nuevas composiciones basadas en una mezcla sinergistica de al menos un ligando vdr y un retinoide. - Google Patents

Nuevas composiciones basadas en una mezcla sinergistica de al menos un ligando vdr y un retinoide.

Info

Publication number
MX9703461A
MX9703461A MX9703461A MX9703461A MX9703461A MX 9703461 A MX9703461 A MX 9703461A MX 9703461 A MX9703461 A MX 9703461A MX 9703461 A MX9703461 A MX 9703461A MX 9703461 A MX9703461 A MX 9703461A
Authority
MX
Mexico
Prior art keywords
ligands
retinoids
vrd
compositions based
novel compositions
Prior art date
Application number
MX9703461A
Other languages
English (en)
Other versions
MXPA97003461A (es
Inventor
Serge Michel
Veronique Dionisius-Pouget
Original Assignee
Ct Internat De Rech S
Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9482603&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9703461(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ct Internat De Rech S, Dermatologiques Galderma filed Critical Ct Internat De Rech S
Publication of MX9703461A publication Critical patent/MX9703461A/es
Publication of MXPA97003461A publication Critical patent/MXPA97003461A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invencion describe una nueva combinacion de uno o más ligandos con actividad selectiva del receptor VDR y uno o más retinoides selectivos para receptores RAR-gamma con respecto a los receptores RAR-alfa, así como al uso de ésta en aplicacion cosmética y cuidados de la piel para el tratamiento de trastornos relacionados con la hiperproliferacion de células, en particular células de la piel, tal como la psoriasis.
MXPA/A/1997/003461A 1995-09-15 1997-05-12 Nuevas composiciones basadas en una mezcla sinergistica de al menos un ligando vdr y un retinoide MXPA97003461A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9510854A FR2738745B1 (fr) 1995-09-15 1995-09-15 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations
FR95/10854 1995-09-15
PCT/FR1996/001386 WO1997009987A1 (fr) 1995-09-15 1996-09-10 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide

Publications (2)

Publication Number Publication Date
MX9703461A true MX9703461A (es) 1997-07-31
MXPA97003461A MXPA97003461A (es) 1997-12-01

Family

ID=

Also Published As

Publication number Publication date
BR9606648A (pt) 1997-09-16
JP2898100B2 (ja) 1999-05-31
BR9606648B1 (pt) 2009-01-13
US6759396B1 (en) 2004-07-06
ATE218349T1 (de) 2002-06-15
PT788361E (pt) 2002-11-29
JPH10503533A (ja) 1998-03-31
AU687687B2 (en) 1998-02-26
WO1997009987A1 (fr) 1997-03-20
EP0788361B1 (fr) 2002-06-05
AU6991296A (en) 1997-04-01
CA2204437C (fr) 2003-06-10
FR2738745A1 (fr) 1997-03-21
CA2204437A1 (fr) 1997-03-20
DK0788361T3 (da) 2002-07-15
FR2738745B1 (fr) 1997-10-24
EP0788361A1 (fr) 1997-08-13
DE69621580D1 (de) 2002-07-11
DE69621580T2 (de) 2003-03-13
ES2181908T3 (es) 2003-03-01
NZ318430A (en) 2000-09-29

Similar Documents

Publication Publication Date Title
AU687687B2 (en) Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids
NZ231832A (en) Pharmaceutical or cosmetic composition for topical application containing microspheres of diameter 3-10mum
ZA932403B (en) Skin care method and composition.
HU9401105D0 (en) Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives
EP0660698A1 (fr) Composition cosmetique ou dermatologique contenant au moins une saponine de type ginsenoside, et ses applications, notamment pour le soin des cheveux.
TW280773B (es)
TR199801501T1 (xx) Yeni form�lasyon.
ATE137665T1 (de) Kosmetisches mittel
CA2135575A1 (fr) Composition cosmetique contenant en tant qu'agent reducteur un n-mercapto-alkyl alcanediamide ou l'un de ses sels cosmetiquement acceptable
DE69407419D1 (de) 2' oder 3' -deoxy- und 2' -dideoxy-beta-l-pentafuranonukleoside, verfahren zur herstellung und anwendung in der therapie, insbesondere als antivirale wirkstoffe
SG81882A1 (en) Retinoid composition
DE69831404D1 (de) Verwendung von mindestens einem irvingia gabonensis-extrakt in kosmetischen und/oder pharmazeutischen produkten
CA2179778A1 (en) Deuterised active agents in transdermal application
WO1998038968A3 (de) Kosmetisches körperpflegepräparat das honig enthält und verfahren zu seiner herstellung
ITPN920030A0 (it) Composizione per uso topico avente attivita' di stimolo per la ricrescita, di rinvigorimento, di prevenzione dell'ingrigimento e di ripigmentazione naturale dei capelli
MY131368A (en) Synthetic detergent total body care product
ES2121463T3 (es) Uso de procisteina como agente blanqueante de la piel.
DE59803222D1 (de) Kosmetische mittel
KR960700729A (ko) 26,26,26,27,27,27-헥사플루오로-1 알파, 25-디히드록시콜레칼시페롤의 칼슘 대사 장애의 치료 용도(Use of 26,26,26,27,27,27-Hexafluoro-1alpha, 25-Dihydroxycholecalciferol for the treatment of Calcium Metabolism Disorders)
RU94008830A (ru) Основа для косметических средств

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees